INN: Nalbuphine
Presentation: solution for injections 20 mg/ml, 1 ml ampoules 5 units per pack
Included in the List of psychotropic substances which circulation in the Russian Federation is restricted and in which respect it shall be permissible to exclude certain measures of control in accordance with the legislation of the Russian Federation and the international treaties of the Russian Federation (List III)
Registration number: LSP-000074
By prescription
Pharmacotherapeutic group: analgesic narcotic drug, opioid receptor agonist-antagonist.
Indications for use:
- severe pain of various genesis (postoperative period, myocardial infarction, gynecological interventions, injuries, malignant tumors)
- as an adjuvant anesthetic for operations under general anesthesia.
Shelf life: 4 years